tiprankstipranks
Trending News
More News >
Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
India Market

Tatva Chintan Pharma Chem Limited (TATVA) Price & Analysis

Compare
0 Followers

TATVA Stock Chart & Stats


Tatva Chintan Pharma Chem Limited News

Financials

TATVA FAQ

What was Tatva Chintan Pharma Chem Limited’s price range in the past 12 months?
Tatva Chintan Pharma Chem Limited lowest stock price was ₹610.00 and its highest was ₹1195.05 in the past 12 months.
    What is Tatva Chintan Pharma Chem Limited’s market cap?
    Tatva Chintan Pharma Chem Limited’s market cap is ₹23.55B.
      When is Tatva Chintan Pharma Chem Limited’s upcoming earnings report date?
      Tatva Chintan Pharma Chem Limited’s upcoming earnings report date is Jul 29, 2025 which is in 21 days.
        How were Tatva Chintan Pharma Chem Limited’s earnings last quarter?
        Tatva Chintan Pharma Chem Limited released its earnings results on May 02, 2025. The company reported ₹0.45 earnings per share for the quarter, beating the consensus estimate of ₹0.2 by ₹0.25.
          Is Tatva Chintan Pharma Chem Limited overvalued?
          According to Wall Street analysts Tatva Chintan Pharma Chem Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Tatva Chintan Pharma Chem Limited pay dividends?
            Tatva Chintan Pharma Chem Limited pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.2%. See more information on Tatva Chintan Pharma Chem Limited dividends here
              What is Tatva Chintan Pharma Chem Limited’s EPS estimate?
              Tatva Chintan Pharma Chem Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Tatva Chintan Pharma Chem Limited have?
              Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding.
                What happened to Tatva Chintan Pharma Chem Limited’s price movement after its last earnings report?
                Tatva Chintan Pharma Chem Limited reported an EPS of ₹0.45 in its last earnings report, beating expectations of ₹0.2. Following the earnings report the stock price went down -0.276%.
                  Which hedge fund is a major shareholder of Tatva Chintan Pharma Chem Limited?
                  Currently, no hedge funds are holding shares in IN:TATVA

                  Company Description

                  Tatva Chintan Pharma Chem Limited

                  Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Fineotex Chemical Limited
                  IOL Chemicals & Pharmaceuticals Ltd.
                  Kiri Industries Limited
                  Punjab Chemicals & Crop Protection Ltd.
                  Yasho Industries Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis